REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,318,106 | +26.3% | 201,586 | +53.4% | 0.00% | +200.0% |
Q2 2023 | $2,627,426 | +12.2% | 131,437 | +6.1% | 0.00% | -50.0% |
Q1 2023 | $2,342,325 | +16.0% | 123,867 | +39.2% | 0.00% | 0.0% |
Q4 2022 | $2,018,769 | -40.6% | 89,011 | -30.8% | 0.00% | 0.0% |
Q3 2022 | $3,400,000 | +37.0% | 128,681 | +28.1% | 0.00% | 0.0% |
Q2 2022 | $2,481,000 | +21.7% | 100,479 | +63.6% | 0.00% | +100.0% |
Q1 2022 | $2,038,000 | -51.9% | 61,403 | -52.6% | 0.00% | -50.0% |
Q4 2021 | $4,238,000 | -22.7% | 129,598 | -0.9% | 0.00% | -33.3% |
Q3 2021 | $5,481,000 | -1.0% | 130,752 | -8.3% | 0.00% | 0.0% |
Q2 2021 | $5,537,000 | +11.6% | 142,517 | -2.0% | 0.00% | 0.0% |
Q1 2021 | $4,961,000 | +20.8% | 145,458 | +60.7% | 0.00% | +50.0% |
Q4 2020 | $4,106,000 | -24.6% | 90,511 | -54.3% | 0.00% | -50.0% |
Q3 2020 | $5,446,000 | +245.6% | 197,879 | +362.5% | 0.00% | +300.0% |
Q2 2020 | $1,576,000 | +17.9% | 42,788 | +3.6% | 0.00% | 0.0% |
Q1 2020 | $1,337,000 | -37.1% | 41,296 | -20.4% | 0.00% | -50.0% |
Q4 2019 | $2,125,000 | -41.2% | 51,867 | -48.9% | 0.00% | -33.3% |
Q3 2019 | $3,612,000 | -26.3% | 101,442 | +6.3% | 0.00% | -25.0% |
Q2 2019 | $4,901,000 | +85.9% | 95,402 | +107.4% | 0.00% | +100.0% |
Q1 2019 | $2,637,000 | -67.2% | 46,003 | -76.0% | 0.00% | -75.0% |
Q4 2018 | $8,030,000 | +12.5% | 191,413 | +102.4% | 0.01% | +33.3% |
Q3 2018 | $7,140,000 | -47.0% | 94,583 | -49.6% | 0.01% | -50.0% |
Q2 2018 | $13,476,000 | +364.8% | 187,812 | +93.4% | 0.01% | +500.0% |
Q1 2018 | $2,899,000 | +8.6% | 97,113 | +21.0% | 0.00% | 0.0% |
Q4 2017 | $2,669,000 | +18.1% | 80,267 | +17.0% | 0.00% | 0.0% |
Q3 2017 | $2,260,000 | +289.7% | 68,582 | +133.7% | 0.00% | +100.0% |
Q2 2017 | $580,000 | +1083.7% | 29,348 | +1042.8% | 0.00% | – |
Q1 2017 | $49,000 | -88.1% | 2,568 | -88.4% | 0.00% | – |
Q4 2016 | $412,000 | +1691.3% | 22,194 | +1255.8% | 0.00% | – |
Q3 2016 | $23,000 | +43.8% | 1,637 | -18.8% | 0.00% | – |
Q2 2016 | $16,000 | -75.0% | 2,016 | -66.0% | 0.00% | – |
Q1 2016 | $64,000 | +77.8% | 5,933 | +171.5% | 0.00% | – |
Q4 2015 | $36,000 | – | 2,185 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |